Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, signaling a newer version of the page content. This change reflects a minor metadata update rather than alterations to study details.
    Difference
    0.0%
    Check dated 2026-04-30T18:53:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Minor version update from v3.5.0 to v3.5.2 with no visible changes to study details or on-page content.
    Difference
    0.0%
    Check dated 2026-04-16T11:10:59.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:27:33.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released. The page content appears unchanged aside from the version label.
    Difference
    0.0%
    Check dated 2026-03-11T17:36:12.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Results have been posted for the study, including ORR, PFS, and OS outcomes with posting dates. The page now includes links to the study protocol and statistical analysis plan.
    Difference
    3%
    Check dated 2026-03-04T13:39:04.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The government funding lapse notice and the v3.4.1 revision information were removed.
    Difference
    0.4%
    Check dated 2026-02-11T06:18:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.